SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Jolly, M
Right arrow Articles by Utset, T O
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jolly, M
Right arrow Articles by Utset, T O
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Lupus
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life?

M Jolly

University of Illinois at Chicago, IL, USA, meenakshijolly{at}netscape.net

T O Utset

University of Chicago, IL, USA

Disease specific measures like systemic lupus erythematosus (SLE) Disease Activity Index (SLEDAI), Systemic Lupus International Collaborating Clinics (SLICC) and Systemic Lupus Activity Measure (SLAM) are primarily based on physician assessment of disease severity along with blood tests pertinent to SLE. These are primarily used for research purposes and do not quantify the social impact of the disease or measure function and well being from the patients perspective. We wish to study the degree of correlation between the SLEDAI, SLICC and patient reported health related quality of life (HRQOL), to see if these measures can be used to gauge the disease impact from the patient’s perspective. The aim of the study was, therefore, to assess the correlation between SLICC, SLEDAI and HRQOL in patients with systemic lupus erythematosus. We utilized the University of Chicago SLE database to obtain SLEDAI, SLICC and MOS SF-36 scores. A physician not directly involved in their care assessed SLEDAI, SLICC and SF-36 at the same visit. STATA-7SE software was used to obtain the two summary scores [physical component summary (PCS) and mental component summary (MCS)]. Multiple linear regression and correlation coefficients were obtained to assess the direction and relationship between HRQOL and these disease specific measures. On multivariate regression models, both SLICC and SLEDAI were predictive of the PCS scores (ßSLICC = -1.036, P = 0.025, 95% CI -1.9, -0.13: ßSLEDAI = -0.322, P = 0.012, 95% CI -0.57, -0.07. R 2 = 0.14). Neither SLICC nor SLEDAI were predictive of MCS scores (ßSLICC = -0.015, P = 0.97, 95% CI -1.03, 1.001: ßSLEDAI = -0.19, P = 0.174, 95% CI -0.47, 0.08. R 2 = 0.02). The correlation coefficients between SLEDAI and PCS, MCS were -0.29 and -0.15, respectively. The correlation coefficients between SLICC and PCS, MCS were -0.27 and -0.02, respectively. The conclusions are that SLEDAI and SLICC are poor indicators of HRQOL of patients with SLE.

Key Words: HRQOL • lupus • SLE • SLEDAI • SLICC

Lupus, Vol. 13, No. 12, 924-926 (2004)
DOI: 10.1191/0961203304lu2034oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
L. Moorthy, M. Peterson, A. Hassett, M Baratelli, E. Chalom, P. Hashkes, S Hong, A Reiff, and T. Lehman
Relationship between health-related quality of life and SLE activity and damage in children over time
Lupus, June 1, 2009; 18(7): 622 - 629.
[Abstract] [PDF]


Home page
The Journal of RheumatologyHome page
R. AGGARWAL, C. T. WILKE, A. S. PICKARD, V. VATS, R. MIKOLAITIS, L. FOGG, J. A. BLOCK, and M. JOLLY
Psychometric Properties of the EuroQol-5D and Short Form-6D in Patients with Systemic Lupus Erythematosus
J Rheumatol, June 1, 2009; 36(6): 1209 - 1216.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
G K Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, et al.
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints
Ann Rheum Dis, April 1, 2009; 68(4): 477 - 483.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
K. Dussan, L Magder, R. Brodsky, R. Jones, and M Petri
High dose cyclophosphamide performs better than monthly dose cyclophosphamide in quality of life measures
Lupus, December 1, 2008; 17(12): 1079 - 1085.
[Abstract] [PDF]


Home page
LupusHome page
L. Moorthy, M. Peterson, M. Harrison, K. Onel, and T. Lehman
Review: Quality of life in children with systemic lupus erythematosus: a review
Lupus, August 1, 2007; 16(8): 663 - 669.
[Abstract] [PDF]


Home page
LupusHome page
K Mcelhone, J Abbott, and L -S Teh
A review of health related quality of life in systemic lupus erythematosus
Lupus, October 1, 2006; 15(10): 633 - 643.
[Abstract] [PDF]


Home page
LupusHome page
M Abu-Shakra, A Keren, I Livshitz, V Delbar, A Bolotin, S Sukenik, and Y Kanat-Maymon
Sense of coherence and its impact on quality of life of patients with systemic lupus erythematosus
Lupus, January 1, 2006; 15(1): 32 - 37.
[Abstract] [PDF]



Advertisement